Why are we doing this study?

Non-alcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease in Australia – because it is so common, patients often have to wait a long time to see a specialist for assessment and treatment. Our study is trying out a different way for patients to be seen – by getting a diagnostic scan done by a trained nurse without having to go to the hospital, rather than waiting to go to a specialist hepatology clinic.

Our researchers think that by having this scan done sooner, clinicians will be able to prioritise those with serious liver disease, and avoid long waits and extra appointments for those with mild disease, who may be able to be cared for by their GP instead.

Below you will find some resources about the project, including a short video that describes the importance of the study, and what will happen to you if you choose to take part.

Participant Resources

LOCATE-NAFLD Factsheet – Click here to find out more about the study design.

About the Fibroscan – Click here for information about what to expect if you are randomised to receive a scan.

About the Researchers – This study is being led by the Australian Centre for Health Services Innovation (AusHSI). Click here to find out more about us.

If there is anything you don’t understand, or want to know more about, please email the study team at LOCATE-NAFLD@qut.edu.au, or call one of our study nurses on 0434 836 111 – we are always happy to provide more information.